These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36514274)

  • 1. Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study.
    Boccia VD; Lapucci C; Cellerino M; Tazza F; Rossi A; Schiavi S; Mancardi MM; Inglese M
    Mult Scler; 2023 Mar; 29(3):475-478. PubMed ID: 36514274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.
    Li J; Huang W; Luo X; Wen Y; Cho J; Kovanlikaya I; Gauthier SA; Nguyen TD; Spincemaille P; Wang Y
    J Neuroimaging; 2022 Jan; 32(1):48-56. PubMed ID: 34664747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
    Kau T; Taschwer M; Deutschmann H; Schönfelder M; Weber JR; Hausegger KA
    Eur Radiol; 2013 Jul; 23(7):1956-62. PubMed ID: 23436147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI.
    Levasseur VA; Xiang B; Salter A; Yablonskiy DA; Cross AH
    J Cent Nerv Syst Dis; 2022; 14():11795735221084842. PubMed ID: 35370433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study.
    Al-Louzi O; Manukyan S; Donadieu M; Absinta M; Letchuman V; Calabresi B; Desai P; Beck ES; Roy S; Ohayon J; Pham DL; Thomas A; Jacobson S; Cortese I; Auluck PK; Nair G; Sati P; Reich DS
    Mult Scler; 2022 Oct; 28(12):1891-1902. PubMed ID: 35674284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the "central vein sign" in infratentorial multiple sclerosis lesions.
    Weber CE; Sandikci V; Ebert A; Szabo K; Platten M; Gass A; Eisele P
    Mult Scler Relat Disord; 2020 Oct; 45():102409. PubMed ID: 32711298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing multiple sclerosis misdiagnosis using the "central vein sign": A real-world study.
    Kaisey M; Solomon AJ; Guerrero BL; Renner B; Fan Z; Ayala N; Luu M; Diniz MA; Sati P; Sicotte NL
    Mult Scler Relat Disord; 2021 Feb; 48():102671. PubMed ID: 33444958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis.
    Daboul L; O'Donnell CM; Cao Q; Amin M; Rodrigues P; Derbyshire J; Azevedo C; Bar-Or A; Caverzasi E; Calabresi P; Cree BAC; Freeman L; Henry RG; Longbrake EE; Nakamura K; Oh J; Papinutto N; Pelletier D; Samudralwar RD; Suthiphosuwan S; Schindler MK; Sotirchos ES; Sicotte NL; Solomon AJ; Shinohara RT; Reich DS; Ontaneda D; Sati P
    AJR Am J Roentgenol; 2023 Jan; 220(1):115-125. PubMed ID: 35975888
    [No Abstract]   [Full Text] [Related]  

  • 10. The central vein sign in multiple sclerosis patients with vascular comorbidities.
    Guisset F; Lolli V; Bugli C; Perrotta G; Absil J; Dachy B; Pot C; Théaudin M; Pasi M; van Pesch V; Maggi P
    Mult Scler; 2021 Jun; 27(7):1057-1065. PubMed ID: 32749948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis: A 3-Year Longitudinal Study.
    Al-Louzi O; Letchuman V; Manukyan S; Beck ES; Roy S; Ohayon J; Pham DL; Cortese I; Sati P; Reich DS
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35027474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult brain volume in multiple sclerosis: The impact of paediatric onset.
    Fenu G; Lorefice L; Loi L; Sechi V; Contu F; Coghe G; Frau J; Spinicci G; Barracciu MA; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2018 Apr; 21():103-107. PubMed ID: 29544192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis.
    Lamot U; Avsenik J; Šega S; Šurlan Popovič K
    Mult Scler Relat Disord; 2017 Apr; 13():67-72. PubMed ID: 28427705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
    Ontaneda D; Sati P; Raza P; Kilbane M; Gombos E; Alvarez E; Azevedo C; Calabresi P; Cohen JA; Freeman L; Henry RG; Longbrake EE; Mitra N; Illenberger N; Schindler M; Moreno-Dominguez D; Ramos M; Mowry E; Oh J; Rodrigues P; Chahin S; Kaisey M; Waubant E; Cutter G; Shinohara R; Reich DS; Solomon A; Sicotte NL;
    Neuroimage Clin; 2021; 32():102834. PubMed ID: 34592690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central vein sign: comparison of multiple sclerosis and leukoaraiosis.
    Yavaş HG; Sağtaş E
    Turk J Med Sci; 2022 Dec; 52(6):1933-1942. PubMed ID: 36945994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency of the "central vein sign" in chronic multiple sclerosis lesions.
    Reichl M; Wittayer M; Weber CE; Platten M; Gass A; Eisele P
    Mult Scler Relat Disord; 2022 Feb; 58():103530. PubMed ID: 35066270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central vein sign: A putative diagnostic marker for multiple sclerosis.
    Chaaban L; Safwan N; Moussa H; El-Sammak S; Khoury SJ; Hannoun S
    Acta Neurol Scand; 2022 Mar; 145(3):279-287. PubMed ID: 34796472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.
    Tranfa M; Tortora M; Pontillo G; Iuzzolino V; Riccio E; Caccavallo S; Di Risi T; Monti S; Lanzillo R; Brescia Morra V; Palma G; Petracca M; Pisani A; Brunetti A; Cocozza S
    Eur Radiol; 2022 Jun; 32(6):3846-3854. PubMed ID: 35029733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
    Luo J; Yablonskiy DA; Hildebolt CF; Lancia S; Cross AH
    Mult Scler; 2014 Mar; 20(3):349-55. PubMed ID: 23836876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis.
    Maggi P; Fartaria MJ; Jorge J; La Rosa F; Absinta M; Sati P; Meuli R; Du Pasquier R; Reich DS; Cuadra MB; Granziera C; Richiardi J; Kober T
    NMR Biomed; 2020 May; 33(5):e4283. PubMed ID: 32125737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.